AR049436A1 - Derivado de propano-1,3-diona o sus sales - Google Patents

Derivado de propano-1,3-diona o sus sales

Info

Publication number
AR049436A1
AR049436A1 ARP050102297A ARP050102297A AR049436A1 AR 049436 A1 AR049436 A1 AR 049436A1 AR P050102297 A ARP050102297 A AR P050102297A AR P050102297 A ARP050102297 A AR P050102297A AR 049436 A1 AR049436 A1 AR 049436A1
Authority
AR
Argentina
Prior art keywords
lower alkyl
substituted
propane
halogen
ring
Prior art date
Application number
ARP050102297A
Other languages
English (en)
Inventor
Masaaki Hirano
Eiji Kawaminami
Shunichiro Matsumoto
Kei Ohnuki
Kazuyoshi Obitsu
Toshiyuki Kusayama
Isao Kinoyama
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of AR049436A1 publication Critical patent/AR049436A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente trata de derivado de propano-1,3-diona o sus sales, composiciones farmacéuticas que los contienen y usos en enfermedades que dependen de las hormonas sexuales. Reivindicacion 1: Un derivado de la propano-1,3-diona representado por la formula general (1) o una de sus sales farmacéuticamente aceptable. [Los símbolos de la formula tienen el significado que se les asigna seguidamente: anillo A: benceno que puede estar sustituido, piridina que puede estar sustituida o anillo de tiofeno; anillo B: benceno o anillo de tiofeno; R1: H o -CO-alquilo inferior; R2: H, -O-R5, -N(R6)R7, -N3, -S(O)m-alquilo inferior, -S(O)m-N(R6)R7, halogeno, piridilo o imidazolilo que puede estar sustituido; R5: H, alquilo inferior, -CO-alquilo inferior que puede estar sustituido o -CO-O-alquilo inferior que puede estar sustituido; R6 y R7: pueden ser iguales o diferentes entre sí y cada uno es H, alquilo inferior o -CO-alquilo inferior, con la condicion de que R1 y R2 juntos formen dioxolano que puede estar sustituido, m es 0, 1 o 2; R3 es H o alquilo inferior; R401 y R402 pueden ser iguales o diferentes entre sí y cada uno es H, halogeno, OH, -O-alquilo inferior o alquilo inferior; X es enlace, alquileno inferior que puede estar sustituido o cicloalcanedilo; R101, R102, R103 y R104: pueden ser iguales o diferentes entre sí y cada uno es H, halogeno, OH o alquilo inferior que puede estar sustituido con -O-(arilo o heteroarilo)].
ARP050102297A 2004-06-04 2005-06-06 Derivado de propano-1,3-diona o sus sales AR049436A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004166486 2004-06-04
JP2005099815 2005-03-30

Publications (1)

Publication Number Publication Date
AR049436A1 true AR049436A1 (es) 2006-08-02

Family

ID=35462868

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102297A AR049436A1 (es) 2004-06-04 2005-06-06 Derivado de propano-1,3-diona o sus sales

Country Status (16)

Country Link
US (2) US7709519B2 (es)
EP (1) EP1752452A4 (es)
JP (1) JP4595938B2 (es)
CN (1) CN1964950A (es)
AR (1) AR049436A1 (es)
AU (1) AU2005250273B2 (es)
BR (1) BRPI0511796A (es)
CA (1) CA2568590C (es)
IL (1) IL179437A (es)
MX (1) MXPA06014131A (es)
NO (1) NO20070074L (es)
NZ (1) NZ552372A (es)
RU (1) RU2347781C2 (es)
TW (1) TWI342307B (es)
UA (1) UA83928C2 (es)
WO (1) WO2005118556A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ552372A (en) 2004-06-04 2009-11-27 Astellas Pharma Inc Propane-1,3-dione derivative or its salt
TW200722420A (en) * 2005-03-31 2007-06-16 Astellas Pharma Inc Propane-1,3-dion derivative or salt thereof
EP2095818A1 (en) * 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
RS56855B1 (sr) * 2010-08-18 2018-04-30 Samumed Llc Diketoni i hidroksiketoni kao aktivatori katenin signalnog puta
CN104603114B (zh) * 2012-09-07 2017-06-20 安斯泰来制药株式会社 磺酰脒化合物的制造方法
BR112015020391B1 (pt) 2013-02-22 2022-07-26 Samumed, Llc Gama-dicetonas como ativadoras da via de sinalização de wnt/beta-catenina
US9618507B2 (en) 2014-02-24 2017-04-11 Betanien Hospital Methods of treating rheumatoid arthritis
BR112017003959B1 (pt) 2014-08-20 2022-08-02 Samumed, Llc Uso de um composto de fórmula i ou um sal dermatologicamente aceitável do mesmo
US10821152B2 (en) 2014-08-26 2020-11-03 Betanien Hospital Methods, agents and compositions for treatment of inflammatory conditions
WO2017170884A1 (ja) * 2016-03-31 2017-10-05 富山化学工業株式会社 新規なヒドロキサム酸誘導体の製造方法およびその中間体

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062686A (en) 1976-04-21 1977-12-13 Eastman Kodak Company Sensitizers for photocrosslinkable polymers
US4263393A (en) 1979-09-06 1981-04-21 Eastman Kodak Company Novel electron donor precursors and photographic element containing them
JPS56161538A (en) 1980-05-16 1981-12-11 Mitsubishi Chem Ind Ltd Photosensitive composition
CA1160226A (en) 1980-07-15 1984-01-10 Gordon H. Phillipps Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor
JPS5964840A (ja) 1982-10-05 1984-04-12 Mitsubishi Chem Ind Ltd 感光性組成物
GB8312721D0 (en) 1983-05-09 1983-06-15 Vickers Plc Photoinitiators
GB8321813D0 (en) 1983-08-12 1983-09-14 Vickers Plc Radiation sensitive compounds
DE3333450A1 (de) 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Trihalogenmethylgruppen enthaltende carbonylmethylenheterocyclen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindungen enthaelt
DD224422A1 (de) 1984-04-27 1985-07-03 Wolfen Filmfab Veb Lichtempfindliches farbfotografisches silberhalogenidmaterial
JPH0760265B2 (ja) 1985-07-02 1995-06-28 三菱化学株式会社 感光性組成物
JPH0820729B2 (ja) 1986-07-25 1996-03-04 三菱化学株式会社 染色可能な感光性組成物
JPH0820695B2 (ja) 1987-04-30 1996-03-04 富士写真フイルム株式会社 ハロゲン化銀感光材料
JPH01205130A (ja) 1988-02-10 1989-08-17 Fuji Photo Film Co Ltd 非線形光学材料
DE3807381A1 (de) 1988-03-07 1989-09-21 Hoechst Ag 4,6-bis-trichlormethyl-s-triazin-2-ylgruppen enthaltende heterocyclische verbindungen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindung enthaelt
EP0333156A3 (en) 1988-03-16 1990-03-21 Fuji Photo Film Co., Ltd. Lithographic plate necessitating no dampening water
JPH01249792A (ja) 1988-03-30 1989-10-05 Nippon Kayaku Co Ltd 新規なオキセタン誘導体およびその製造法
JPH087437B2 (ja) 1988-08-19 1996-01-29 富士写真フイルム株式会社 光重合性組成物
JPH0279007A (ja) 1988-09-16 1990-03-19 Sumitomo Electric Ind Ltd 被覆光ファイバ
JPH0766168B2 (ja) 1988-10-04 1995-07-19 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料
EP0368327B1 (en) 1988-11-11 1995-02-15 Fuji Photo Film Co., Ltd. Light-sensitive composition
JP2639722B2 (ja) 1989-01-18 1997-08-13 富士写真フイルム株式会社 感光性組成物
US5112743A (en) 1989-05-24 1992-05-12 Fuji Photo Film Co., Ltd. Light-sensitive composition and presensitized plate for use in making lithographic printing plates
US4950640A (en) 1989-06-16 1990-08-21 Eastman Kodak Company Infrared absorbing merocyanine dyes for dye-donor element used in laser-induced thermal dye transfer
JP2552550B2 (ja) 1989-07-24 1996-11-13 富士写真フイルム株式会社 感光性組成物
JPH03164722A (ja) 1989-11-24 1991-07-16 Fuji Photo Film Co Ltd 有機非線形光学材料およびそれを用いた光波長の変換方法
JPH03259150A (ja) 1990-03-08 1991-11-19 Mitsubishi Kasei Corp 感光性組成物
JPH04334369A (ja) 1991-05-02 1992-11-20 Fuji Photo Film Co Ltd 四級塩化合物、メチン化合物およびメチン化合物の製造方法
JP2764769B2 (ja) 1991-06-24 1998-06-11 富士写真フイルム株式会社 光重合性組成物
AU662997B2 (en) 1992-07-03 1995-09-21 Ihara Chemical Industry Co. Ltd. Condensed heterocyclic derivative and weedkiller
JP2955803B2 (ja) 1992-07-22 1999-10-04 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
US5593818A (en) 1993-06-22 1997-01-14 Fuji Photo Film Co., Ltd. Silver halide photographic material
US5414620A (en) 1993-08-09 1995-05-09 Honeywell Inc. Synthetic friction algorithm for a hand control element
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
JP3290316B2 (ja) 1994-11-18 2002-06-10 富士写真フイルム株式会社 感光性平版印刷版
US6395733B1 (en) 1995-06-07 2002-05-28 Pfizer Inc Heterocyclic ring-fused pyrimidine derivatives
JPH0961992A (ja) 1995-08-23 1997-03-07 Fuji Photo Film Co Ltd 感光性平版印刷版
CA2229201A1 (en) 1995-10-19 1997-04-24 Satoshi Sasaki Quinoline derivatives, their production and use
JP3506295B2 (ja) 1995-12-22 2004-03-15 富士写真フイルム株式会社 ポジ型感光性平版印刷版
US5747236A (en) 1996-01-26 1998-05-05 Eastman Kodak Company Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
US5747235A (en) 1996-01-26 1998-05-05 Eastman Kodak Company Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
CA2254756A1 (en) 1996-05-20 1997-11-27 Mark Goulet Antagonists of gonadotropin releasing hormone
DE19630229A1 (de) 1996-07-26 1998-01-29 Bayer Ag Pyrazinderivate
US6140384A (en) 1996-10-02 2000-10-31 Fuji Photo Film Co., Ltd. Photopolymerizable composition containing a sensitizing dye with cyano or substituted carbonyl groups
US6051359A (en) 1996-11-25 2000-04-18 Fuji Photo Film Co., Ltd. Heat developable light-sensitive material and method of forming color images
US5994051A (en) 1997-07-25 1999-11-30 Eastman Kodak Company Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
EP0893732B1 (en) 1997-07-25 2003-01-22 Eastman Kodak Company Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
AU3430699A (en) 1998-04-08 1999-11-01 Washington Odur Ayuko Butenolide derivatives as anti-cancer agents
EP0985683A1 (en) 1998-09-09 2000-03-15 Fuji Photo Film Co., Ltd. Photosensitive composition and method for manufacturing lithographic printing plate
US6346534B1 (en) 1998-09-23 2002-02-12 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
JP2000095767A (ja) 1998-09-28 2000-04-04 Takeda Chem Ind Ltd 性腺刺激ホルモン放出ホルモン拮抗剤
DE19928033A1 (de) 1999-06-18 2000-12-21 Basf Ag Verwendung von cyclischen Enaminen als Lichtschutzmittel
CA2415010C (en) 2000-07-05 2011-05-03 Yamanouchi Pharmaceutical Co., Ltd. Propane-1,3-dione derivatives useful as gnrh receptor antagonist
JP2002088284A (ja) 2000-09-14 2002-03-27 Fuji Photo Film Co Ltd インクジェット記録用インク組成物及びインクジェット記録方法
JP2002241758A (ja) 2001-02-16 2002-08-28 Fuji Photo Film Co Ltd 液晶組成物および液晶素子
JP2002268239A (ja) 2001-03-06 2002-09-18 Fuji Photo Film Co Ltd 印刷版の製版方法
IL156777A0 (en) 2001-04-30 2004-02-08 Zentaris Gmbh Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists
JP2004061583A (ja) 2002-07-25 2004-02-26 Fuji Photo Film Co Ltd 平版印刷版の製版方法
JP3902523B2 (ja) 2002-08-05 2007-04-11 富士フイルム株式会社 光情報記録媒体および情報記録方法
ITMI20031855A1 (it) 2003-09-29 2005-03-30 Isagro Ricerca Srl Derivati di 1,3-dioni aventi attivita' erbicida.
WO2005097090A2 (en) 2004-04-05 2005-10-20 Icos Corporation AGENTS THAT DISRUPT PSD95 - nNOS INTERACTION, COMPOSITIONS CONTAINING THE SAME, AND THERAPEUTIC USES THEREOF
NZ552372A (en) 2004-06-04 2009-11-27 Astellas Pharma Inc Propane-1,3-dione derivative or its salt

Also Published As

Publication number Publication date
EP1752452A9 (en) 2007-12-12
RU2006142689A (ru) 2008-06-10
CN1964950A (zh) 2007-05-16
IL179437A (en) 2011-11-30
US20100173946A1 (en) 2010-07-08
US7709519B2 (en) 2010-05-04
JP4595938B2 (ja) 2010-12-08
EP1752452A4 (en) 2010-07-14
UA83928C2 (ru) 2008-08-26
NZ552372A (en) 2009-11-27
US8076367B2 (en) 2011-12-13
EP1752452A1 (en) 2007-02-14
JPWO2005118556A1 (ja) 2008-04-03
CA2568590A1 (en) 2005-12-15
MXPA06014131A (es) 2007-03-07
US20090018177A1 (en) 2009-01-15
BRPI0511796A (pt) 2008-01-15
TWI342307B (en) 2011-05-21
CA2568590C (en) 2011-01-18
WO2005118556A1 (ja) 2005-12-15
RU2347781C2 (ru) 2009-02-27
NO20070074L (no) 2007-03-02
AU2005250273B2 (en) 2010-10-14
AU2005250273A1 (en) 2005-12-15
TW200613281A (en) 2006-05-01
IL179437A0 (en) 2007-05-15

Similar Documents

Publication Publication Date Title
AR049436A1 (es) Derivado de propano-1,3-diona o sus sales
BRPI0411916A (pt) imidazoquinolinas substituìdas por sulfonamida
AR064049A1 (es) Derivados de acidos carboxilicos unidos a heterociclos, composiciones farmaceuticas que los contienen, y usos como promotores de la secrecion de insulina en el tratamiento de la diabetes mellitus.
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
AR070352A1 (es) Derivado de pirrolopirimidina como inhibidor de la enzima pi3k, un procedimiento de elaboracion del compuesto, una composicion farmaceutica y un agente preventivo o terapeutico en base al compuesto.
AR094876A1 (es) Derivados de ácido betulínico modificados con alquilo c-3 y alquenilo
AR077413A1 (es) Derivados piridin-4-ilo
BR0116026A (pt) Imidazoquinolinas substituìdas por tioéter
ME00454B (me) Nova so perindoprila i farmaceutske kompozicije koje sadrže tu so
CR20150313A (es) Composiciones farmacéuticas
BR112015030948A2 (pt) Derivados de glp-1 e usos dos mesmos
BRPI0718966B8 (pt) composto, composição farmacêutica, inibidor plk1 e agente antitumoral
CR10420A (es) Derivados biciclicos como inhibibidores de cetp
MA34147B1 (fr) Composes tricycliques fusionnes de silyle et leurs methodes d'utilisation dans le cadre du traitement de maladies virales
CO5721006A2 (es) Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa
CY1109925T1 (el) Η χρηση πυριδυλ αμιδιων ως παρεμποδιστων της αγγειογενεσης
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
AR045906A1 (es) Composicion farmaceutica para mejorar la solubilidad de farmacos hidrofobicos
AR094812A1 (es) Derivado de piridina monocíclico como inhibidor del fgfr
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
BR112012011310A2 (pt) compostos derivados de 8-azabiciclo[3.2.1]octano-8-carboxamida, seu medicamento, seu agente terapêutico e seu uso
ECSP088689A (es) NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS
UY26780A1 (es) Cicloalquil avb3 antagonistas
AR102258A1 (es) Compuestos de quinolina y quinazolina
BR112015020952A2 (pt) compostos antivirais

Legal Events

Date Code Title Description
FA Abandonment or withdrawal